vimarsana.com
Home
Live Updates
FDA Approval of Lecanemab for Alzheimer's: Experts Weigh In
FDA Approval of Lecanemab for Alzheimer's: Experts Weigh In
FDA Approval of Lecanemab for Alzheimer's: Experts Weigh In
Last week's FDA approval of the anti-amyloid lecanemab is being hailed by some Alzheimer's experts as a major advance; others are less certain and have concerns about the drug's efficacy, safety, and cost.
Related Keywords
Minnesota ,
United States ,
Amsterdam ,
Noord Holland ,
Netherlands ,
United Kingdom ,
Mayo Clinic In Rochester ,
Rob Howard ,
Ronald Petersen ,
Howard Fillit ,
Eli Lilly ,
David Knopman ,
University College London ,
Alzheimer Association International Conference ,
Alzheimer Drug Discovery Foundation ,
Mayo Clinic Alzheimer Disease Research Center ,
Drug Administration ,
Mayo Clinic Alzheimer ,
Disease Research Center ,
Medscape Medical News ,
New England Journal ,
Clinical Dementia Rating Sum ,
Cognitive Subscale ,
Mayo Clinic ,
Medscape Medical ,
Serious Side Effect Risk ,
Drug Discovery Foundation ,
Major Issue ,
Association International Conference ,